Annexin Pharmaceuticals Ab Stock Number Of Shares Shorted
| ANNX Stock | SEK 0.50 0.01 1.96% |
Annexin Pharmaceuticals AB fundamentals help investors to digest information that contributes to Annexin Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Annexin Stock. The fundamental analysis module provides a way to measure Annexin Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Annexin Pharmaceuticals stock.
Annexin |
Annexin Pharmaceuticals AB Company Number Of Shares Shorted Analysis
Annexin Pharmaceuticals' Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
| Competition |
Based on the recorded statements, Annexin Pharmaceuticals AB has 0.0 of outstending shares currently sold short by investors. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The number of shares shorted for all Sweden stocks is 100.0% higher than that of the company.
Did you try this?
Run Funds Screener Now
Funds ScreenerFind actively-traded funds from around the world traded on over 30 global exchanges |
| All Next | Launch Module |
Annexin Fundamentals
| Return On Equity | -1.06 | |||
| Return On Asset | -0.57 | |||
| Current Valuation | 125.48 M | |||
| Shares Outstanding | 154.5 M | |||
| Shares Owned By Insiders | 45.17 % | |||
| Shares Owned By Institutions | 5.06 % | |||
| Price To Book | 4.90 X | |||
| EBITDA | (50.28 M) | |||
| Net Income | (52.14 M) | |||
| Cash And Equivalents | 22.77 M | |||
| Cash Per Share | 1.29 X | |||
| Debt To Equity | 1.20 % | |||
| Current Ratio | 9.56 X | |||
| Book Value Per Share | 0.20 X | |||
| Cash Flow From Operations | (45.02 M) | |||
| Earnings Per Share | (0.43) X | |||
| Target Price | 2.0 | |||
| Beta | 1.55 | |||
| Market Capitalization | 189.95 M | |||
| Total Asset | 52.79 M | |||
| Net Asset | 52.79 M |
About Annexin Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Annexin Pharmaceuticals AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Annexin Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Annexin Pharmaceuticals AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Annexin Stock Analysis
When running Annexin Pharmaceuticals' price analysis, check to measure Annexin Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annexin Pharmaceuticals is operating at the current time. Most of Annexin Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Annexin Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Annexin Pharmaceuticals' price. Additionally, you may evaluate how the addition of Annexin Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.